Penn researchers find increase in disability among older, obese adults

November 06, 2007

PHILADELPHIA - Researchers at the University of Pennsylvania School of Medicine report that older adults today are much more likely to suffer from disability than those 10 years ago. This research - the first to track effects of obesity on disability over time - appears in the November 7th issue of the Journal of the American Medical Association.

"Obesity is more hazardous to the health of the elderly than we previously suspected," says Dawn Alley, PhD, lead author, and Robert Wood Johnson Health and Society Scholar at the University of Pennsylvania School of Medicine. "For an older person, suffering from obesity means they are much less likely to be able to walk to the front door or pick up a bag of groceries."

The study reveals that obesity, which has become more common among older Americans, is having an increasingly profound impact on their day-to-day activities and overall health. By comparing health data from 1988-1994 to data from 1999-2004, the researchers found that the odds of suffering from functional impairment have increased 43 percent among obese adults age 60 years and older. This means they are less able to do things like walk a quarter of a mile, climb 10 steps, pick up a 10-pound weight, and bend over.

"We believe that two factors are likely contributing to the rise in disability among older, obese people," says Virginia Chang, MD, PhD, Assistant Professor of Medicine at Penn; Attending Physician, Philadelphia Veterans Affairs Medical Center; and senior study author. "First, people are potentially living longer with their obesity due to improved medical care, and second, people are becoming obese at younger ages than in the past. In both instances, people are living with obesity for longer periods of time, which increases the potential for disability."

The study evaluated health survey data from 9,928 Americans age 60 years and over from the National Heath and Nutrition Examination Surveys (NHANES) conducted from 1988 to 1994 and from 1999 to 2004. Researchers estimated the risk of functional and activities of daily living (ADL) impairment - the inability to move from a bed, dress, or eat - for normal weight, overweight, and obese populations for both time periods, and evaluated trends in the relationship between obesity and disability over time. Results revealed that obesity increased by 8.2% among the population over 60 during this time period, and that the disability gap between obese and non-obese groups widened.

Researchers also found that obese people are not benefiting from some of the health improvements that the rest of the population is experiencing. For example, although the odds of ADL impairment decreased by 34 percent among the general population, no such improvements were seen in the obese population.

Other recent studies have suggested that obese populations have actually become healthier since the 1960s. While other obesity-related risk factors - such as high blood pressure and elevated cholesterol - have declined, this new research suggests that quality of life for obese older people may be deteriorating.

"Preventing disability should be another motivation for health care providers, policymakers and the public to take obesity seriously in the elderly population. Spending time and resources to prevent obesity now may reduce the need to treat disabilities later," says Dr. Alley.
-end-
The study was supported by the Robert Wood Johnson Foundation Health and Society Scholars Program and by a grant from the National Institute of Child Health and Human Development.

PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is currently ranked #3 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals -- its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation's "Honor Roll" hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first

University of Pennsylvania School of Medicine

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.